JASON MASTOR: Open Payments
NPI 1598857401 · MOORESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,965 in 243 payments from 20 companies in 2025. Trend: 2023 $3,622 · 2024 $3,426 · 2025 $4,965
Food & beverage: $3,975Travel & lodging: $990
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 16 | $1,290 |
| Teva Pharmaceuticals USA, Inc. | 32 | $554 |
| E.R. Squibb & Sons, L.L.C. | 18 | $495 |
| ABBVIE INC. | 61 | $471 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $410 |
| Otsuka America Pharmaceutical, Inc. | 16 | $356 |
| Neurocrine BioSciences, Inc. | 15 | $302 |
| Vanda Pharmaceuticals Inc. | 14 | $240 |
| Axsome Therapeutics, Inc. | 18 | $205 |
| Lundbeck LLC | 9 | $153 |
Products named: SPRAVATO, AUSTEDO XR, COBENFY, VRAYLAR, REXULTI, CAPLYTA, INGREZZA, FANAPT.
Industry payments across NC — which companies pay providers there.
